Scientist-operator bridging life sciences, AI & corporate strategy
PhD in Physical Chemistry (École Normale Supérieure) and an Executive MBA (Collège des Ingénieurs). I translate complex science and AI into clear strategy — advising biotech startups and pharma on R&D portfolio decisions, diagnostics and go-to-market.
My professional trajectory has been shaped by a dual ambition: to do rigorous science that directly applies to the real world. I have always wanted to operate at the forefront of my field, bridging the gap between fundamental research and practical application to solve tangible problems.
To avoid the path of a pure academic, I pursued a PhD in Physical Chemistry at the École Normale Supérieure concurrently with an MBA at the Collège des Ingénieurs. This combination allowed me to work with a molecular diagnostics startup under a CIFRE fellowship during my doctoral studies, translating lab work into a commercial setting. After my PhD, I joined Sanofi, where I designed capability strategies for large-scale organizational transformations.
Driven by a desire to build, I later went fully into entrepreneurship. I tried a few early-stage startup ideas and failed, which taught me concrete lessons about product-market fit and the realities of building a business. These iterations led me naturally into consulting. Today, I work with biotech startups on their go-to-market plans, regulatory frameworks, and general product positioning.
My interest in systems optimization also carries over to my personal projects. I build automated tools, systems, and data pipelines using Python, databases, and advanced analytics to integrate AI into daily workflows. I also apply this data-driven mindset to my own biology as an analytical biohacker, focusing on metrics and tracking rather than supplements.
Outside of my work, you can find me sailing or skiing. I trained at the Les Glénans sailing school, am a member of the West Pier Sailing Club in Dún Laoghaire, and enjoy sailing in Brittany. In the winter, I ski across France, Switzerland, and Austria, and I also enjoy training in combat sports, having practiced MMA, Brazilian Jiu-Jitsu, and Muay Thai.
On this site, you will find a mix of my professional work, personal projects, and various interests in different forms. Welcome, and feel free to explore.
Degrees, roles and ventures on a single timeline — overlapping bars show what ran in parallel. Select any row to read more.
Four-year honours degree in chemical and pharmaceutical sciences, with a research thesis. 2nd Class Honours.
Research masters at the interface of chemistry and biology. Graduated Mention Très Bien — 1st Class Honours.
Led product registrations across 9 South-East Asian countries; advised regulatory affairs officers on compliance requirements.
Recurring one-to-two-month contracts supporting formulation development and EU CLP regulatory classifications — run in parallel with the MSc, PhD and BforCure work.
Co-developed qPCR kits for COVID-19 and respiratory viruses. Oversaw design, installation and regulatory compliance of the chemistry lab; supervised 2 interns.
Executive MBA in Science Management, taken within the Collège des Ingénieurs fellowship — a competitive three-year programme (under 5% admission) that combined the doctorate with rotational placements at leading European firms.
"Innovative Strategies for DNA Analysis using Supramolecular Assemblies and qPCR Multiplexing." Developed high-content PCR (hcPCR) — a multiplexing method that resolves multiple targets per optical channel by deconvolving each probe's temperature–fluorescence signature — and discovered light-based detection of single-point mutations in short DNA sequences.
Investment scout and content/community manager — deal sourcing and community building.
Vice-President of the Collège des Ingénieurs alumni association — building the French alumni community through networking events and TED-talk projects.
Founded a deep-tech biotech venture out of PSL Research University in partnership with a multinational pharmaceutical company. Led company structure, negotiation strategy and market positioning; concluded the venture in 2024 after evaluating commercial viability against alternative paths into strategy consulting.
Founded and built an AI-powered biotech investment-intelligence platform covering 350+ US and EU tickers — parsing SEC filings, tracking FDA/EMA catalysts and generating sentiment scores and daily executive summaries. Also leads the associated investment club.
Project-managed the organisational transformation of 2,400 employees, lifting productivity ~10%. Future-proofed organisational health and improved decision-making structures — a rotational placement within the Collège des Ingénieurs fellowship.
Designed and shipped Gist — a native macOS app that turns speech into polished email, prompts and notes in any app, with transcription and AI running 100% on-device (Gemma via Apple MLX): no cloud, no account. Also built an on-device speaking coach that trains clearer, more confident delivery from your own dictations. Stack: SwiftUI, MLX.
Independent strategy consulting for pharma and biotech clients across Switzerland, France and Germany. Led the market positioning and portfolio analysis behind a multi-billion-euro decision on a large European pharma's obesity-drug assets, and developed R&D portfolio, go-to-market and optimisation strategies for top pharmaceutical clients. Acting QMS lead for a large pharmaceutical client, with strategic frameworks delivering ~20% operational efficiency gains.
Selected for a competitive 3-month founder programme. Explored personalised diagnostics, electrochemical biosensors and DNA computing before returning focus to Micromagnetix.
My PhD at the École Normale Supérieure (PSL University) — Innovative Strategies for DNA Analysis using Supramolecular Assemblies and qPCR Multiplexing — built new ways to read more information out of a DNA test. I've rebuilt three of its core ideas as interactive models you can explore.
Molecular beacons that capture a short target and chain themselves into a self-assembling supramolecular network.
Explore the model Chapter 3A second melting fingerprint, Tm*, that pulls single-base mutations apart on a two-dimensional map.
Explore the model Chapter 2Reading several targets from a single optical channel by their fluorescence–temperature waveforms.
Explore the modelAI-Powered Biotech Investment Intelligence
An AI-powered biotech investment intelligence platform covering 350+ US and EU tickers. It uses Python and the Google Gemini API to parse SEC filings, track FDA/EMA catalysts, and generate sentiment scores and daily executive summaries for investors.
Private On-Device AI Dictation for macOS
A native macOS app that turns your voice into polished email, prompts, messages and notes in any app — with transcription and AI running 100% on your Mac. No cloud, no account. It also includes an on-device speaking coach that helps you deliver clearer, more confident dictation, with every word staying private to your machine.
Essays and analysis on biotech strategy, molecular diagnostics, AI and the business of science. A selection below — the full archive, with publications, lives on the articles page.
I'm based in Paris and open to discussing opportunities in Strategy, Biotech, and Tech.
Email: [email protected]
Phone: +33 6 28 37 04 38